-
2
-
-
33847327365
-
Benchmarks for the assessment of novel cardiovascular biomarkers
-
DOI 10.1161/CIRCULATIONAHA.106.683110, PII 0000301720070227000004
-
Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007;115:949-52. (Pubitemid 46328287)
-
(2007)
Circulation
, vol.115
, Issue.8
, pp. 949-952
-
-
Morrow, D.A.1
De Lemos, J.A.2
-
3
-
-
34548394664
-
National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure
-
Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007;116:e99-109.
-
(2007)
Circulation
, vol.116
-
-
Tang, W.H.1
Francis, G.S.2
Morrow, D.A.3
Newby, L.K.4
Cannon, C.P.5
Jesse, R.L.6
-
4
-
-
79953035510
-
Evaluating the clinical utility of a biomarker: A review of methods for estimating health impact
-
Pletcher MJ, Pignone M. Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact. Circulation 2011;123:1116-24.
-
(2011)
Circulation
, vol.123
, pp. 1116-1124
-
-
Pletcher, M.J.1
Pignone, M.2
-
5
-
-
43549099569
-
Biomarkers in heart failure
-
Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-59.
-
(2008)
N Engl J Med
, vol.358
, pp. 2148-2159
-
-
Braunwald, E.1
-
6
-
-
79960786335
-
Risk stratification and short-term prognosis in acute heart failure syndromes: A review of novel biomarkers
-
Avellino A, Collins SP, Fermann GJ. Risk stratification and short-term prognosis in acute heart failure syndromes: A review of novel biomarkers. Biomarkers. 2011;16:379-92.
-
(2011)
Biomarkers
, vol.16
, pp. 379-392
-
-
Avellino, A.1
Collins, S.P.2
Fermann, G.J.3
-
8
-
-
67349125810
-
The evolution of the natriuretic peptides: Current applications in human and animal medicine
-
van Kimmenade RR, Januzzi JL Jr. The evolution of the natriuretic peptides: current applications in human and animal medicine. J Vet Cardiol. 2009;11(Suppl 1):S9-21.
-
(2009)
J Vet Cardiol
, vol.11
, Issue.SUPPL. 1
-
-
Van Kimmenade, R.R.1
Januzzi Jr., J.L.2
-
9
-
-
79952661776
-
Pro-B-type natriuretic peptide(1-108) circulates in the general community: Plasma determinants and detection of left ventricular dysfunction
-
Macheret F, Boerrigter G, McKie P, Costello-Boerrigter L, Lahr B, Heublein D, et al. Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2011;57:1386-95.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 1386-1395
-
-
Macheret, F.1
Boerrigter, G.2
McKie, P.3
Costello-Boerrigter, L.4
Lahr, B.5
Heublein, D.6
-
10
-
-
79955773505
-
Natriuretic peptide testing in heart failure
-
Kim HN, Januzzi JL Jr. Natriuretic peptide testing in heart failure. Circulation 2011;123:2015-9.
-
(2011)
Circulation
, vol.123
, pp. 2015-2019
-
-
Kim, H.N.1
Januzzi Jr., J.L.2
-
11
-
-
73449123365
-
B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies
-
Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 2009;120:2177-87.
-
(2009)
Circulation
, vol.120
, pp. 2177-2187
-
-
Di Angelantonio, E.1
Chowdhury, R.2
Sarwar, N.3
Ray, K.K.4
Gobin, R.5
Saleheen, D.6
-
12
-
-
0034176934
-
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
-
Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30. (Pubitemid 30172933)
-
(2000)
Lancet
, vol.355
, Issue.9210
, pp. 1126-1130
-
-
Troughton, R.W.1
Frampton, C.M.2
Yandle, T.G.3
Espiner, E.A.4
Nicholls, M.G.5
Richards, A.M.6
-
13
-
-
78649983509
-
Biomarker-guided treatment of heart failure: Still waiting for a definitive answer
-
Troughton RW, Frampton CM, Nicholls MG. Biomarker-guided treatment of heart failure: still waiting for a definitive answer. J Am Coll Cardiol 2010;56:2101-4.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 2101-2104
-
-
Troughton, R.W.1
Frampton, C.M.2
Nicholls, M.G.3
-
14
-
-
76449120415
-
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study
-
Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 2010;55:645-53.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 645-653
-
-
Berger, R.1
Moertl, D.2
Peter, S.3
Ahmadi, R.4
Huelsmann, M.5
Yamuti, S.6
-
15
-
-
77951646726
-
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: Results from the BACH (Biomarkers in Acute Heart Failure) trial
-
Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010;55:2062-76.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2062-2076
-
-
Maisel, A.1
Mueller, C.2
Nowak, R.3
Peacock, W.F.4
Landsberg, J.W.5
Ponikowski, P.6
-
16
-
-
0037432179
-
Identification of serum soluble ST2 receptor as a novel heart failure biomarker
-
DOI 10.1161/01.CIR.0000047274.66749.FE
-
Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003;107:721-6. (Pubitemid 36222600)
-
(2003)
Circulation
, vol.107
, Issue.5
, pp. 721-726
-
-
Weinberg, E.O.1
Shimpo, M.2
Hurwitz, S.3
Tominaga, S.-I.4
Rouleau, J.-L.5
Lee, R.T.6
-
17
-
-
77949264462
-
Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling
-
Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail 2009;2:684-91.
-
(2009)
Circ Heart Fail
, vol.2
, pp. 684-691
-
-
Seki, K.1
Sanada, S.2
Kudinova, A.Y.3
Steinhauser, M.L.4
Handa, V.5
Gannon, J.6
-
18
-
-
53249113212
-
The IL-33/ST2 pathway: Therapeutic target and novel biomarker
-
Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008;7:827-40.
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 827-840
-
-
Kakkar, R.1
Lee, R.T.2
-
19
-
-
34547582106
-
Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea. Results From the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) Study
-
DOI 10.1016/j.jacc.2007.05.014, PII S0735109707016993
-
Januzzi JL, Jr., Peacock WF, Maisel AS, Chae CU, Jesse RL, Baggish AL, et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 2007;50:607-13. (Pubitemid 47199007)
-
(2007)
Journal of the American College of Cardiology
, vol.50
, Issue.7
, pp. 607-613
-
-
Januzzi Jr., J.L.1
Peacock, W.F.2
Maisel, A.S.3
Chae, C.U.4
Jesse, R.L.5
Baggish, A.L.6
O'Donoghue, M.7
Sakhuja, R.8
Chen, A.A.9
Van Kimmenade, R.R.J.10
Lewandrowski, K.B.11
Lloyd-Jones, D.M.12
Wu, A.H.B.13
-
20
-
-
73549108878
-
Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea
-
Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail 2009;2:311-9.
-
(2009)
Circ Heart Fail
, vol.2
, pp. 311-319
-
-
Shah, R.V.1
Chen-Tournoux, A.A.2
Picard, M.H.3
Van Kimmenade, R.R.4
Januzzi, J.L.5
-
21
-
-
79960026972
-
Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: Complementary role for risk stratification in acutely decompensated heart failure
-
Pascual-Figal DA, Manzano-Fernandez S, Boronat M, Casas T, Garrido IP, Bonaque JC, et al. Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011;13:718-25.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 718-725
-
-
Pascual-Figal, D.A.1
Manzano-Fernandez, S.2
Boronat, M.3
Casas, T.4
Garrido, I.P.5
Bonaque, J.C.6
-
22
-
-
78649291119
-
Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure
-
Bayes-Genis A, Pascual-Figal D, Januzzi JL, Maisel A, Casas T, Valdes Chavarri M, et al. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure. Rev Esp Cardiol 2010;63:1171-8.
-
(2010)
Rev Esp Cardiol
, vol.63
, pp. 1171-1178
-
-
Bayes-Genis, A.1
Pascual-Figal, D.2
Januzzi, J.L.3
Maisel, A.4
Casas, T.5
Valdes Chavarri, M.6
-
23
-
-
70349813786
-
Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - The Presage ST2 assay
-
Dieplinger B, Januzzi JL Jr, Steinmair M, Gabriel C, Poelz W, Haltmayer M, et al. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - the Presage ST2 assay. Clin Chim Acta 2009;409:33-40.
-
(2009)
Clin Chim Acta
, vol.409
, pp. 33-40
-
-
Dieplinger, B.1
Januzzi Jr., J.L.2
Steinmair, M.3
Gabriel, C.4
Poelz, W.5
Haltmayer, M.6
-
24
-
-
33646076691
-
The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
-
Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006;98:351-60.
-
(2006)
Circ Res
, vol.98
, pp. 351-360
-
-
Kempf, T.1
Eden, M.2
Strelau, J.3
Naguib, M.4
Willenbockel, C.5
Tongers, J.6
-
25
-
-
77958507769
-
Serial measurement of growth-differentiation factor-15 in heart failure: Relation to disease severity and prognosis in the Valsartan Heart Failure Trial
-
Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, et al. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial. Circulation 2010;122:1387-95.
-
(2010)
Circulation
, vol.122
, pp. 1387-1395
-
-
Anand, I.S.1
Kempf, T.2
Rector, T.S.3
Tapken, H.4
Allhoff, T.5
Jantzen, F.6
-
26
-
-
8644230017
-
Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions
-
DOI 10.1007/s00441-004-0986-3
-
Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 2004;318:325-33. (Pubitemid 39506502)
-
(2004)
Cell and Tissue Research
, vol.318
, Issue.2
, pp. 325-333
-
-
Schlittenhardt, D.1
Schober, A.2
Strelau, J.3
Bonaterra, G.A.4
Schmiedt, W.5
Unsicker, K.6
Metz, J.7
Kinscherf, R.8
-
27
-
-
3142688226
-
Anemia and its relationship to clinical outcome in heart failure
-
DOI 10.1161/01.CIR.0000134279.79571.73
-
Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110:149-54. (Pubitemid 38924582)
-
(2004)
Circulation
, vol.110
, Issue.2
, pp. 149-154
-
-
Anand, I.1
McMurray, J.J.V.2
Whitmore, J.3
Warren, M.4
Pham, A.5
McCamish, M.A.6
Burton, P.B.J.7
-
28
-
-
70349983577
-
Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure
-
Miller WL, Hartman KA, Burritt MF, Grill DE, Jaffe AS. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2009;54:1715-21.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 1715-1721
-
-
Miller, W.L.1
Hartman, K.A.2
Burritt, M.F.3
Grill, D.E.4
Jaffe, A.S.5
-
29
-
-
34948887646
-
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure
-
DOI 10.1161/CIRCULATIONAHA.106.655076
-
Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9. (Pubitemid 47517535)
-
(2007)
Circulation
, vol.116
, Issue.11
, pp. 1242-1249
-
-
Latini, R.1
Masson, S.2
Anand, I.S.3
Missov, E.4
Carlson, M.5
Vago, T.6
Angelici, L.7
Barlera, S.8
Parrinello, G.9
Maggioni, A.P.10
Tognoni, G.11
Cohn, J.N.12
-
30
-
-
71849117655
-
Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure
-
Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J 2010;159:63-7.
-
(2010)
Am Heart J
, vol.159
, pp. 63-67
-
-
Tsutamoto, T.1
Kawahara, C.2
Nishiyama, K.3
Yamaji, M.4
Fujii, M.5
Yamamoto, T.6
-
31
-
-
79960024453
-
Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure
-
Tentzeris I, Jarai R, Farhan S, Perkmann T, Schwarz MA, Jakl G, et al. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail 2011;13:726-33.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 726-733
-
-
Tentzeris, I.1
Jarai, R.2
Farhan, S.3
Perkmann, T.4
Schwarz, M.A.5
Jakl, G.6
-
32
-
-
78650400736
-
Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure
-
Xue Y, Clopton P, Peacock WF, Maisel AS. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail 2011;13:37-42.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 37-42
-
-
Xue, Y.1
Clopton, P.2
Peacock, W.F.3
Maisel, A.S.4
-
33
-
-
11244355392
-
A study of C-reactive protein in the serum of patients with congestive heart failure
-
Elster SK, Braunwald E, Wood HF. A study of C-reactive protein in the serum of patients with congestive heart failure. Am Heart J 1956;51:533-41.
-
(1956)
Am Heart J
, vol.51
, pp. 533-541
-
-
Elster, S.K.1
Braunwald, E.2
Wood, H.F.3
-
34
-
-
79851486666
-
Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction
-
Matsubara J, Sugiyama S, Nozaki T, Sugamura K, Konishi M, Ohba K, et al. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. J Am Coll Cardiol 2011;57:861-9.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 861-869
-
-
Matsubara, J.1
Sugiyama, S.2
Nozaki, T.3
Sugamura, K.4
Konishi, M.5
Ohba, K.6
-
35
-
-
77951639762
-
Inflammatory markers and incident heart failure risk in older adults: The Health ABC (Health, Aging, and Body Composition) study
-
Kalogeropoulos A, Georgiopoulou V, Psaty BM, Rodondi N, Smith AL, Harrison DG, et al. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol 2010;55:2129-37.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2129-2137
-
-
Kalogeropoulos, A.1
Georgiopoulou, V.2
Psaty, B.M.3
Rodondi, N.4
Smith, A.L.5
Harrison, D.G.6
-
36
-
-
36849086574
-
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
-
DOI 10.1016/j.ahj.2007.08.013, PII S0002870307006886
-
Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 2008;155:75-81. (Pubitemid 350234768)
-
(2008)
American Heart Journal
, vol.155
, Issue.1
, pp. 75-81
-
-
Suzuki, S.1
Takeishi, Y.2
Niizeki, T.3
Koyama, Y.4
Kitahara, T.5
Sasaki, T.6
Sagara, M.7
Kubota, I.8
-
37
-
-
4744348381
-
In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure
-
DOI 10.1152/ajpheart.00036.2004
-
Moe GW, Marin-Garcia J, Konig A, Goldenthal M, Lu X, Feng Q. In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 2004;287:H1813-20. (Pubitemid 39313290)
-
(2004)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.287
, Issue.4
-
-
Moe, G.W.1
Marin-Garcia, J.2
Konig, A.3
Goldenthal, M.4
Lu, X.5
Feng, Q.6
-
38
-
-
0034808012
-
Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo
-
DOI 10.1007/s004240100612
-
Patten M, Kramer E, Bunemann J, Wenck C, Thoenes M, Wieland T, et al. Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo. Pflugers Arch 2001;442:920-7. (Pubitemid 32900453)
-
(2001)
Pflugers Archiv European Journal of Physiology
, vol.442
, Issue.6
, pp. 920-927
-
-
Patten, M.1
Kramer, E.2
Bunemann, J.3
Wenck, C.4
Thoenes, M.5
Wieland, T.6
Long, C.7
-
39
-
-
0037465808
-
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study
-
DOI 10.1161/01.CIR.0000057810.48709.F6
-
Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003;107:1486-91. (Pubitemid 36378485)
-
(2003)
Circulation
, vol.107
, Issue.11
, pp. 1486-1491
-
-
Vasan, R.S.1
Sullivan, L.M.2
Roubenoff, R.3
Dinarello, C.A.4
Harris, T.5
Benjamin, E.J.6
Sawyer, D.B.7
Levy, D.8
Wilson, P.W.F.9
D'Agostino, R.B.10
-
40
-
-
0035942264
-
Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone Trial (VEST)
-
Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-9. (Pubitemid 32373007)
-
(2001)
Circulation
, vol.103
, Issue.16
, pp. 2055-2059
-
-
Deswal, A.1
Petersen, N.J.2
Feldman, A.M.3
Young, J.B.4
White, B.G.5
Mann, D.L.6
-
41
-
-
11144355760
-
Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
-
DOI 10.1161/01.CIR.0000124490.27666.B2
-
Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004;109:1594-602. (Pubitemid 38451714)
-
(2004)
Circulation
, vol.109
, Issue.13
, pp. 1594-1602
-
-
Mann, D.L.1
McMurray, J.J.V.2
Packer, M.3
Swedberg, K.4
Borer, J.S.5
Colucci, W.S.6
Djian, J.7
Drexler, H.8
Feldman, A.9
Kober, L.10
Krum, H.11
Liu, P.12
Nieminen, M.13
Tavazzi, L.14
Van Veldhuisen, D.J.15
Waldenstrom, A.16
Warren, M.17
Westheim, A.18
Zannad, F.19
Fleming, T.20
more..
-
42
-
-
69549111120
-
Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis
-
Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 2009;120:699-708.
-
(2009)
Circulation
, vol.120
, pp. 699-708
-
-
Norata, G.D.1
Marchesi, P.2
Pulakazhi Venu, V.K.3
Pasqualini, F.4
Anselmo, A.5
Moalli, F.6
-
43
-
-
40749084822
-
Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction
-
Salio M, Chimenti S, De Angelis N, Molla F, Maina V, Nebuloni M, et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008;117:1055-64.
-
(2008)
Circulation
, vol.117
, pp. 1055-1064
-
-
Salio, M.1
Chimenti, S.2
De Angelis, N.3
Molla, F.4
Maina, V.5
Nebuloni, M.6
-
44
-
-
77953013954
-
Use of myeloperoxidase for risk stratification in acute heart failure
-
Reichlin T, Socrates T, Egli P, Potocki M, Breidthardt T, Arenja N, et al. Use of myeloperoxidase for risk stratification in acute heart failure. Clin Chem 2010;56:944-51.
-
(2010)
Clin Chem
, vol.56
, pp. 944-951
-
-
Reichlin, T.1
Socrates, T.2
Egli, P.3
Potocki, M.4
Breidthardt, T.5
Arenja, N.6
-
45
-
-
65249159202
-
Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure
-
Tang WH, Katz R, Brennan ML, Aviles RJ, Tracy RP, Psaty BM, et al. Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure. Am J Cardiol 2009;103:1269-74.
-
(2009)
Am J Cardiol
, vol.103
, pp. 1269-1274
-
-
Tang, W.H.1
Katz, R.2
Brennan, M.L.3
Aviles, R.J.4
Tracy, R.P.5
Psaty, B.M.6
-
46
-
-
58149263078
-
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea
-
Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S, et al. Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Clin Chem 2009;55:59-67.
-
(2009)
Clin Chem
, vol.55
, pp. 59-67
-
-
Shah, K.B.1
Kop, W.J.2
Christenson, R.H.3
Diercks, D.B.4
Kuo, D.5
Henderson, S.6
-
47
-
-
79960596886
-
Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure
-
Zile MR, Desantis SM, Baicu CF, Stroud RE, Thompson SB, McClure CD, et al. Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure. Circ Heart Fail 2011;4:246-56.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 246-256
-
-
Zile, M.R.1
Desantis, S.M.2
Baicu, C.F.3
Stroud, R.E.4
Thompson, S.B.5
McClure, C.D.6
-
48
-
-
77955303165
-
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
-
Ho CY, Lopez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010;363:552-63.
-
(2010)
N Engl J Med
, vol.363
, pp. 552-563
-
-
Ho, C.Y.1
Lopez, B.2
Coelho-Filho, O.R.3
Lakdawala, N.K.4
Cirino, A.L.5
Jarolim, P.6
-
49
-
-
77953109129
-
Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment
-
Kanoupakis EM, Manios EG, Kallergis EM, Mavrakis HE, Goudis CA, Saloustros IG, et al. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol 2010;55:2753-9.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2753-2759
-
-
Kanoupakis, E.M.1
Manios, E.G.2
Kallergis, E.M.3
Mavrakis, H.E.4
Goudis, C.A.5
Saloustros, I.G.6
-
50
-
-
0034727695
-
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES)
-
Rales Investigators
-
Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 2000;102:2700-6.
-
(2000)
Circulation
, vol.102
, pp. 2700-2706
-
-
Zannad, F.1
Alla, F.2
Dousset, B.3
Perez, A.4
Pitt, B.5
-
51
-
-
77649187120
-
Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure
-
Buralli S, Dini FL, Ballo P, Conti U, Fontanive P, Duranti E, et al. Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure. Am J Cardiol 2010;105:853-6.
-
(2010)
Am J Cardiol
, vol.105
, pp. 853-856
-
-
Buralli, S.1
Dini, F.L.2
Ballo, P.3
Conti, U.4
Fontanive, P.5
Duranti, E.6
-
52
-
-
41449108661
-
Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality
-
Frantz S, Stork S, Michels K, Eigenthaler M, Ertl G, Bauersachs J, et al. Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality. Eur J Heart Fail 2008;10:388-95.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 388-395
-
-
Frantz, S.1
Stork, S.2
Michels, K.3
Eigenthaler, M.4
Ertl, G.5
Bauersachs, J.6
-
53
-
-
41549117493
-
Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage
-
DOI 10.1152/ajpheart.00305.2007
-
Sharma U, Rhaleb NE, Pokharel S, Harding P, Rasoul S, Peng H, et al. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Am J Physiol Heart Circ Physiol 2008;294:H1226-32. (Pubitemid 351468718)
-
(2008)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.294
, Issue.3
-
-
Sharma, U.1
Rhaleb, N.-E.2
Pokharel, S.3
Harding, P.4
Rasoul, S.5
Peng, H.6
Carretero, O.A.7
-
54
-
-
70349975735
-
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
-
Lin YH, Lin LY, Wu YW, Chien KL, Lee CM, Hsu RB, et al. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta 2009;409:96-9.
-
(2009)
Clin Chim Acta
, vol.409
, pp. 96-99
-
-
Lin, Y.H.1
Lin, L.Y.2
Wu, Y.W.3
Chien, K.L.4
Lee, C.M.5
Hsu, R.B.6
-
55
-
-
33748415221
-
Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure
-
DOI 10.1016/j.jacc.2006.03.061, PII S0735109706016767
-
van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF, et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 2006;48:1217-24. (Pubitemid 44345127)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.6
, pp. 1217-1224
-
-
Van Kimmenade, R.R.1
Januzzi Jr., J.L.2
Ellinor, P.T.3
Sharma, U.C.4
Bakker, J.A.5
Low, A.F.6
Martinez, A.7
Crijns, H.J.8
MacRae, C.A.9
Menheere, P.P.10
Pinto, Y.M.11
-
56
-
-
77954658143
-
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: Data from the DEAL-HF study
-
Lok DJ, Van Der Meer P, de la Porte PW, Lipsic E, Van Wijngaarden J, Hillege HL, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 2010;99:323-8.
-
(2010)
Clin Res Cardiol
, vol.99
, pp. 323-328
-
-
Lok, D.J.1
Van Der Meer, P.2
De La Porte, P.W.3
Lipsic, E.4
Van Wijngaarden, J.5
Hillege, H.L.6
-
57
-
-
0030444643
-
The endothelin system and its potential as a therapeutic target in cardiovascular disease
-
DOI 10.1016/S0163-7258(96)00101-5, PII S0163725896001015
-
Gray GA, Webb DJ. The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther 1996;72:109-48. (Pubitemid 26423301)
-
(1996)
Pharmacology and Therapeutics
, vol.72
, Issue.2
, pp. 109-148
-
-
Gray, G.A.1
Webb, D.J.2
-
58
-
-
0029880929
-
Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
-
DOI 10.1016/0735-1097(95)00520-X
-
Pacher R, Stanek B, Hulsmann M, Koller-Strametz J, Berger R, Schuller M, et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996;27:633-41. (Pubitemid 26081922)
-
(1996)
Journal of the American College of Cardiology
, vol.27
, Issue.3
, pp. 633-641
-
-
Pacher, R.1
Stanek, B.2
Hulsmann, M.3
Koller-Strametz, J.4
Berger, R.5
Schuller, M.6
Hartter, E.7
Ogris, E.8
Frey, B.9
Heinz, G.10
Maurer, G.11
-
59
-
-
77955516734
-
Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure
-
Tang WH, Shrestha K, Martin MG, Borowski AG, Jasper S, Yandle TG, et al. Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure. J Card Fail 2010;16:635-40.
-
(2010)
J Card Fail
, vol.16
, pp. 635-640
-
-
Tang, W.H.1
Shrestha, K.2
Martin, M.G.3
Borowski, A.G.4
Jasper, S.5
Yandle, T.G.6
-
60
-
-
0036774973
-
Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
-
DOI 10.1016/S0167-5273(02)00182-1, PII S0167527302001821
-
Kalra PR, Moon JC, Coats AJ. Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int J Cardiol 2002;85:195-7. (Pubitemid 35245980)
-
(2002)
International Journal of Cardiology
, vol.85
, Issue.2-3
, pp. 195-197
-
-
Kalra, P.R.1
Moon, J.C.C.2
Coats, A.J.S.3
-
61
-
-
0030924922
-
Cardiac inotropic actions of urocortin in conscious sheep
-
Parkes DG, Vaughan J, Rivier J, Vale W, May CN. Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 1997;272:H2115-22.
-
(1997)
Am J Physiol
, vol.272
-
-
Parkes, D.G.1
Vaughan, J.2
Rivier, J.3
Vale, W.4
May, C.N.5
-
62
-
-
26444587528
-
Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure
-
DOI 10.1093/eurheartj/ehi351
-
Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Lainchbury JG, Richards AM. Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure. Eur Heart J 2005;26:2055-62. (Pubitemid 41435727)
-
(2005)
European Heart Journal
, vol.26
, Issue.19
, pp. 2055-2062
-
-
Rademaker, M.T.1
Charles, C.J.2
Espiner, E.A.3
Frampton, C.M.4
Lainchbury, J.G.5
Richards, A.M.6
-
63
-
-
70350448974
-
Plasma urocortin 1 in human heart failure
-
Wright SP, Doughty RN, Frampton CM, Gamble GD, Yandle TG, Richards AM. Plasma urocortin 1 in human heart failure. Circ Heart Fail 2009;2:465-71.
-
(2009)
Circ Heart Fail
, vol.2
, pp. 465-471
-
-
Wright, S.P.1
Doughty, R.N.2
Frampton, C.M.3
Gamble, G.D.4
Yandle, T.G.5
Richards, A.M.6
-
64
-
-
2142639428
-
Plasma urocortin in human systolic heart failure
-
DOI 10.1042/CS20030311
-
Ng LL, Loke IW, O'Brien RJ, Squire IB, Davies JE. Plasma urocortin in human systolic heart failure. Clin Sci 2004;106:383-8. (Pubitemid 38553586)
-
(2004)
Clinical Science
, vol.106
, Issue.4
, pp. 383-388
-
-
Ng, L.1
Loke, I.W.2
O'Brien, R.J.3
Squire, I.B.4
Davies, J.E.5
-
65
-
-
17444382670
-
Neurohormonal activation in congestive heart failure and the role of vasopressin
-
DOI 10.1016/j.amjcard.2005.03.003, Hyponatemia in Congestive Heart Failure
-
Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol. 2005;95:8B-13B. (Pubitemid 40545927)
-
(2005)
American Journal of Cardiology
, vol.95
, Issue.9 SUPPL. 1
-
-
Chatterjee, K.1
-
66
-
-
77954755974
-
Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: Results from the International Collaborative of NT-proBNP Study
-
Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, et al. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail 2010;3:354-61.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 354-361
-
-
Mohammed, A.A.1
Van Kimmenade, R.R.2
Richards, M.3
Bayes-Genis, A.4
Pinto, Y.5
Moore, S.A.6
-
67
-
-
29744438811
-
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
-
DOI 10.1373/clinchem.2005.060038
-
Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112-9. (Pubitemid 43032474)
-
(2006)
Clinical Chemistry
, vol.52
, Issue.1
, pp. 112-119
-
-
Morgenthaler, N.G.1
Struck, J.2
Alonso, C.3
Bergmann, A.4
-
68
-
-
79957521352
-
Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure
-
Alehagen U, Dahlstrom U, Rehfeld JF, Goetze JP. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA 2011;305:2088-95.
-
(2011)
JAMA
, vol.305
, pp. 2088-2095
-
-
Alehagen, U.1
Dahlstrom, U.2
Rehfeld, J.F.3
Goetze, J.P.4
-
69
-
-
63449090676
-
AVP receptor antagonists in patients with CHF
-
Kumar SK, Mather PJ. AVP receptor antagonists in patients with CHF. Heart Fail Rev 2009;14(2):83-6.
-
(2009)
Heart Fail Rev
, vol.14
, Issue.2
, pp. 83-86
-
-
Kumar, S.K.1
Mather, P.J.2
-
70
-
-
79955926423
-
Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction
-
Klip IT, Voors AA, Anker SD, Hillege HL, Struck J, Squire I, et al. Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 2011;97:892-8.
-
(2011)
Heart
, vol.97
, pp. 892-898
-
-
Klip, I.T.1
Voors, A.A.2
Anker, S.D.3
Hillege, H.L.4
Struck, J.5
Squire, I.6
-
71
-
-
33749519022
-
Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure. Redefining the Cardiorenal Interaction?
-
DOI 10.1016/j.jacc.2006.06.056, PII S0735109706019061
-
van Kimmenade RR, Januzzi JL Jr, Baggish AL, Lainchbury JG, Bayes-Genis A, Richards AM, et al. Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol 2006;48:1621-7. (Pubitemid 44528169)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.8
, pp. 1621-1627
-
-
Van Kimmenade, R.R.J.1
Januzzi Jr., J.L.2
Baggish, A.L.3
Lainchbury, J.G.4
Bayes-Genis, A.5
Richards, A.M.6
Pinto, Y.M.7
-
72
-
-
34248176428
-
Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure. Results from the International Collaborative of NT-proBNP (ICON) Study
-
DOI 10.1016/j.cca.2007.03.010, PII S0009898107001416
-
Baggish AL, van Kimmenade R, Bayes-Genis A, Davis M, Lainchbury JG, Frampton C, et al. Hemoglobin and N-terminal pro-brain natriuretic peptide: independent and synergistic predictors of mortality in patients with acute heart failure. Results from the International Collaborative of NT-proBNP (ICON) Study. Clin Chim Acta 2007;381:145-50. (Pubitemid 46719148)
-
(2007)
Clinica Chimica Acta
, vol.381
, Issue.2
, pp. 145-150
-
-
Baggish, A.L.1
Van Kimmenade, R.2
Bayes-Genis, A.3
Davis, M.4
Lainchbury, J.G.5
Frampton, C.6
Pinto, Y.7
Richards, M.A.8
Januzzi, J.L.9
-
73
-
-
34250747440
-
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure. Data From the CHARM Program and the Duke Databank
-
DOI 10.1016/j.jacc.2007.02.067, PII S0735109707012703
-
Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007;50:40-7. (Pubitemid 46963527)
-
(2007)
Journal of the American College of Cardiology
, vol.50
, Issue.1
, pp. 40-47
-
-
Felker, G.M.1
Allen, L.A.2
Pocock, S.J.3
Shaw, L.K.4
McMurray, J.J.V.5
Pfeffer, M.A.6
Swedberg, K.7
Wang, D.8
Yusuf, S.9
Michelson, E.L.10
Granger, C.B.11
-
74
-
-
38049148378
-
Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease
-
Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-8.
-
(2008)
Circulation
, vol.117
, pp. 163-168
-
-
Tonelli, M.1
Sacks, F.2
Arnold, M.3
Moye, L.4
Davis, B.5
Pfeffer, M.6
-
75
-
-
75149149379
-
Red blood cell distribution width and 1-year mortality in acute heart failure
-
van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi JL Jr. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010;12:129-36.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 129-136
-
-
Van Kimmenade, R.R.1
Mohammed, A.A.2
Uthamalingam, S.3
Van Der Meer, P.4
Felker, G.M.5
Januzzi Jr., J.L.6
-
76
-
-
79953206194
-
Free and easy? Red cell distribution width (RDW) and prognosis in cardiac disease
-
Means RT Jr. Free and easy? Red cell distribution width (RDW) and prognosis in cardiac disease. J Card Fail 2011;17:299-300.
-
(2011)
J Card Fail
, vol.17
, pp. 299-300
-
-
Means Jr., R.T.1
-
77
-
-
77549085145
-
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure
-
Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010;16:230-8.
-
(2010)
J Card Fail
, vol.16
, pp. 230-238
-
-
Allen, L.A.1
Felker, G.M.2
Mehra, M.R.3
Chiong, J.R.4
Dunlap, S.H.5
Ghali, J.K.6
-
78
-
-
85009068658
-
The function of the kidneys in patients suffering from chronic cardiac disease without signs of heart failure
-
Stewart H, McIntosh JF. The function of the kidneys in patients suffering from chronic cardiac disease without signs of heart failure. J Clin Invest 1928;6:325-45.
-
(1928)
J Clin Invest
, vol.6
, pp. 325-345
-
-
Stewart, H.1
McIntosh, J.F.2
-
79
-
-
0034564507
-
Cystatin C-properties and use as diagnostic marker
-
Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000;35:63-99.
-
(2000)
Adv Clin Chem
, vol.35
, pp. 63-99
-
-
Grubb, A.O.1
-
80
-
-
15944397332
-
Cystatin C concentration as a risk factor for heart failure in older adults
-
Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 2005;142:497-505.
-
(2005)
Ann Intern Med
, vol.142
, pp. 497-505
-
-
Sarnak, M.J.1
Katz, R.2
Stehman-Breen, C.O.3
Fried, L.F.4
Jenny, N.S.5
Psaty, B.M.6
-
81
-
-
79851476270
-
Beta-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure
-
Manzano-Fernandez S, Januzzi JL Jr, Boronat-Garcia M, Bonaque-Gonzalez JC, Truong QA, Pastor-Perez FJ, et al. beta-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am Coll Cardiol 2011;57:849-58.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 849-858
-
-
Manzano-Fernandez, S.1
Januzzi Jr., J.L.2
Boronat-Garcia, M.3
Bonaque-Gonzalez, J.C.4
Truong, Q.A.5
Pastor-Perez, F.J.6
-
82
-
-
33846682720
-
Dual action of neutrophil gelatinase-associated lipocalin
-
DOI 10.1681/ASN.2006080882
-
Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007;18:407-13. (Pubitemid 46193306)
-
(2007)
Journal of the American Society of Nephrology
, vol.18
, Issue.2
, pp. 407-413
-
-
Schmidt-Ott, K.M.1
Mori, K.2
Jau, Y.L.3
Kalandadze, A.4
Cohen, D.J.5
Devarajan, P.6
Barasch, J.7
-
83
-
-
66249141980
-
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
-
Yndestad A, Landro L, Ueland T, Dahl CP, Flo TH, Vinge LE, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J 2009;30:1229-36.
-
(2009)
Eur Heart J
, vol.30
, pp. 1229-1236
-
-
Yndestad, A.1
Landro, L.2
Ueland, T.3
Dahl, C.P.4
Flo, T.H.5
Vinge, L.E.6
-
84
-
-
79957821843
-
Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure
-
Shrestha K, Borowski AG, Troughton RW, Thomas JD, Klein AL, Tang WH. Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure. J Card Fail 2011;17:472-8.
-
(2011)
J Card Fail
, vol.17
, pp. 472-478
-
-
Shrestha, K.1
Borowski, A.G.2
Troughton, R.W.3
Thomas, J.D.4
Klein, A.L.5
Tang, W.H.6
-
85
-
-
77955447813
-
Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate
-
Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010;96:1297-302.
-
(2010)
Heart
, vol.96
, pp. 1297-1302
-
-
Damman, K.1
Van Veldhuisen, D.J.2
Navis, G.3
Vaidya, V.S.4
Smilde, T.D.5
Westenbrink, B.D.6
-
86
-
-
80053623096
-
Clinical outcome of renal tubular damage in chronic heart failure
-
Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C, et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 2011;32:2705-12.
-
(2011)
Eur Heart J
, vol.32
, pp. 2705-2712
-
-
Damman, K.1
Masson, S.2
Hillege, H.L.3
Maggioni, A.P.4
Voors, A.A.5
Opasich, C.6
-
87
-
-
79957570488
-
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function
-
Damman K, Ng Kam Chuen MJ, MacFadyen RJ, Lip GY, Gaze D, Collinson PO, et al. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 2011;57:2233-41.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 2233-2241
-
-
Damman, K.1
Ng Kam Chuen, M.J.2
MacFadyen, R.J.3
Lip, G.Y.4
Gaze, D.5
Collinson, P.O.6
|